EON BREAST | THE UNIFIED SOLUTION

Screening saves lives. But it isn’t enough.

Incidental breast findings carry a significantly higher cancer risk — but most programs aren’t built to manage them. Eon Breast changes that.

Request a demo

An analysis of data from 53 community-based, acute hospitals reveals why a screening-only approach leaves your high-risk patients undetected.

Patients with incidental findings are fundamentally different.
‍And clinically urgent.*

6.2x

More likely to be
diagnosed with
breast cancer

Patients with incidental breast findings are 6.2 times more likely to receive a breast cancer diagnosis compared to routine screening.

1.3x

More likely to
be high-risk at
initial exam

Among patients diagnosed with cancer, 63% of those with incidental findings were high-risk at their initial exam, compared to 47% of screening patients.

>50%

Fall outside
routine screening
eligibility

More than half of cancers diagnosed through incidental findings were among patients not eligible for routine screening — too young, too old, or male.

These patients are already in your system.
They’re just not in your breast program.

Breast findings surface across every imaging modality. Most programs have no way to ensure they are acted on.

Incidental findings often lack clear ownership

Findings documented in radiology reports are often for patients who have come in for something entirely unrelated to breast care. Without a structured program to capture them, there is no reliable path to ensure those patients received timely follow-up.

Operational burdens put a limit on program capacity

Technologists are stretched thin juggling appointment schedules, patient and provider communications, and MQSA compliance. With workforce shortages and rising demand for services, there is limited bandwidth to manage incidental findings at scale.

Site-by-site silos limit system-wide management

From binders to spreadsheets to disparate mammography platforms, processes and tools vary across facilities. Without cross-site visibility or coordination, compliance and patient retention efforts risk falling short at the enterprise level.

One workflow — centered on the patient — not the entry point.

Eon Breast is the only platform that manages both routine mammography screening and incidental breast findings in a single workflow — with embedded Breast Care Navigators augmenting your existing staff.

Every patient in one workflow — no matter how they were found.

Break the silos of 
early detection

Detect unexpected imaging or evolving risk and adjust the care plan automatically.

Dynamically adapt 
follow-up care

Focus your team’s time on care, not outreach and documentation.

Shift admin time to
clinical time

Get a complete picture at intake, with Tyrer-Cuzick scoring for risk-aligned care.

Lifetime risk scoring
built in

Screening and incidentals, in one workflow

Single dashboard with shared visibility
Longitudinal patient journey management
Intake lifetime risk tool with Tyrer-Cuzick scoring
Risk-aligned, personalized follow-up pathways
Follow-up completion + time-to-resolution tracking
Executive reporting insights for decision support

MQSA inspection-ready, always

Automated, audit-ready reporting embedded
Guideline-driven automated patient communications
Letter audit report and communication tracking
Navigator support for administration and validation
MQSA reporting available in just one click

The Eon navigator differentiator.

Patient calls, letters, and follow-up outreach consume technologist hours. Eon’s embedded Breast Care Navigators take on those tasks so your team can focus on patients.

Scale your impact, not your effort.

Eon Breast ensures every patient with a breast abnormality is identified, followed, and brought to resolution. For Lifepoint Health, this helped drive clinical impact, operational capacity, and program growth.*

1 in 8

Net new patients
identified through
breast incidentals

Patients who would have been missed entirely in a screening-only early detection model.

4 hours

Staff capacity
restored per site
per week

Freed from administrative tasks to focus on patient care.

2.7x

Increase in completed
monthly downstream
exams

Consistent performance contributed to expanding care opportunities for programs live for more than a year.

“As a mammographer, we worry about who’s not returning. Did they get their letter? How do we reach them? Those things just roll through our mind — a lot of times in the middle of the night. With Eon and the Breast Care Navigator team, we share that accountability. It takes a lot of the burden and pressure off your mammographers.”

Tiffany Dean, Program Director, Healthy Person Program, Lifepoint Health

The patients who need you most aren't always the ones who walk into your breast center.

See how Eon Breast can help your program find every patient who needs follow-up — regardless of how they were identified.

Request a consult

Screening saves lives. But it isn’t enough.

An analysis of data from 53 community-based, acute hospitals reveals why a screening-only approach leaves your high-risk patients undetected.

Patients with incidental findings are fundamentally different.
‍And clinically urgent.*

These patients are already in your system.
They’re just not in your breast program.

Incidental findings often lack clear ownership

Operational burdens put a limit on program capacity

Site-by-site silos limit system-wide management

One workflow — centered on the patient — not the entry point.

Screening and incidentals, in one workflow

MQSA inspection-ready, always

The Eon navigator differentiator.

Scale your impact, not your effort.

The patients who need you most aren't always the ones who walk into your breast center.

Dive deeper into Eon's impact, innovation, and insights on breast care.

Breast Incidental Findings: A Quality and Patient Safety Imperative

Insights from Lifepoint's 53-Site Breast Program Transformation

Why screening is not enough

How Eon pushes the boundaries of breast cancer survivability

Screening saves lives. But it isn’t enough.

An analysis of data from 53 community-based, acute hospitals reveals why a screening-only approach leaves your high-risk patients undetected.

Patients with incidental findings are fundamentally different. ‍And clinically urgent.*

These patients are already in your system. They’re just not in your breast program.

Incidental findings often lack clear ownership

Operational burdens put a limit on program capacity

Site-by-site silos limit system-wide management

One workflow — centered on the patient — not the entry point.

Screening and incidentals, in one workflow

MQSA inspection-ready, always

The Eon navigator differentiator.

Scale your impact, not your effort.

The patients who need you most aren't always the ones who walk into your breast center.

Dive deeper into Eon's impact, innovation, and insights on breast care.

Breast Incidental Findings: A Quality and Patient Safety Imperative

Insights from Lifepoint's 53-Site Breast Program Transformation

Why screening is not enough

How Eon pushes the boundaries of breast cancer survivability

Patients with incidental findings are fundamentally different.
‍And clinically urgent.*

These patients are already in your system.
They’re just not in your breast program.